David Peggs

Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate

Tipu Z. Aziz, David Peggs, M.A. Sambrook et al. · Movement Disorders · 1991 · 536 citations

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Ian Mitchell, Carl E Clarke, S. Boyce et al. · Neuroscience · 1989 · 458 citations

Neurophysiology, Neuroanatomy, Neural Mechanisms +12

Dietary administration of a commercial mixed-species probiotic improves growth performance and modulates the intestinal immunity of tilapia, Oreochromis niloticus

Benedict Standen, David Peggs, Mark Rawling et al. · Fish & Shellfish Immunology · 2015 · 223 citations · Full text

Biology, Nutrition, Dietary Administration +11

Modulation of the intestinal microbiota and morphology of tilapia, Oreochromis niloticus, following the application of a multi-species probiotic

Benedict Standen, Ana Rodiles, David Peggs et al. · Applied Microbiology and Biotechnology · 2015 · 193 citations · Full text

Biology, Microbiota Structure, Probiotic +11

The ?2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions ofL-dopa in the MPTP-lesioned primate model of Parkinson's disease

Brian Henry, Susan H. Fox, David Peggs et al. · Movement Disorders · 1999 · 134 citations